Dividend.com’s “Global Retailer With 40+ Years of Dividend Growth” Tease
During these crazy market moves, a lot of us are keeping in the back of our mind a notion along the lines of, “hey, this might be the chance to buy something cheap… but it better be really, really...
View Article58,300% Sales Surge for “Super Vaccine” Company?
Newsletters have taken to hiring spokespeople for their promo videos, trying to give them that extra flash of veritas and professionalism and a nice “anchor voice”, and this time it’s actress and...
View ArticleCOVID 19: What Are Prospects for the Duration?
The term “the duration” immediately recalls the Second World War. Nobody had any idea when it would be over, and so discussions of a lot of World War II-related events and conditions prominently...
View ArticleTwo more of Woods’“Guardian Angel” Stocks
Yesterday I spent some time on a pitch for a “Diamond in the Rough” stock from Jim Woods and promised to follow up… so that’s the plan this afternoon. The bigger theme of the ad was that Woods has a...
View ArticleCOVID Updates and October ’21 Miscellany
A friend of ours on the Maine island where we spent our vacation told us that her husband’s surgery had been cancelled at the last minute because the hospital in Portland was swamped with COVID cases,...
View ArticleCOVID-19: What Now?
Most of this Doc Gumshoe posting was ready to go a couple of days before Thanksgiving. But then, you know what happened: the new variant (now named Omicron) surfaced in South Africa. So I finished up...
View ArticleMarch 2022 Bulletins — Brief, but Relevant
On balance, these bits tend more to the positive than the negative, including a few positive items about COVID-19. (But then, it seems that most of the news about COVID-19 is on the positive side these...
View ArticleFollowing Up on Your Suggestions – September 2022
No surprise, the first comment to Doc Gumshoe’s piece on inflammation was this simple statement: “Next, I would like to read about anti-inflammatories.” It probably would have made sense to follow up...
View ArticleFriday File: More High Yield Speculation
We were pretty fortunate to catch the preferred shares of DigitalBridge (DBRG) at a good price about a month ago, and I’ve continued to poke around in the world of high-yield bonds and preferred...
View ArticleWyatt’s picks for “Coronavirus Biotech Boom?”
Ian Wyatt has been out over the past couple weeks with some “webinars” in which he talks up the coronavirus outbreak (for an hour!) and then ends his show with a tease about several “special reports”...
View Article